232 related articles for article (PubMed ID: 10982389)
21. Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies.
Naef R; Suter U
Neurobiol Dis; 1999 Feb; 6(1):1-14. PubMed ID: 10078969
[TBL] [Abstract][Full Text] [Related]
22. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
[TBL] [Abstract][Full Text] [Related]
23. Mutation analysis of PMP22 in Slovak patients with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies.
Resko P; Radvansky J; Odnogova Z; Baldovic M; Minarik G; Polakova H; Palffy R; Kadasi L
Gen Physiol Biophys; 2011 Dec; 30(4):379-88. PubMed ID: 22131320
[TBL] [Abstract][Full Text] [Related]
24. Sequence of human GAS3/PMP22 full-length cDNA.
Edomi P; Martinotti A; Colombo MP; Schneider C
Gene; 1993 Apr; 126(2):289-90. PubMed ID: 8482547
[TBL] [Abstract][Full Text] [Related]
25. Analysis of compound heterozygous mice reveals that the Trembler mutation can behave as a gain-of-function allele.
Adlkofer K; Naef R; Suter U
J Neurosci Res; 1997 Sep; 49(6):671-80. PubMed ID: 9335255
[TBL] [Abstract][Full Text] [Related]
26. Subcellular diversion of cholesterol by gain- and loss-of-function mutations in PMP22.
Zhou Y; Borchelt D; Bauson JC; Fazio S; Miles JR; Tavori H; Notterpek L
Glia; 2020 Nov; 68(11):2300-2315. PubMed ID: 32511821
[TBL] [Abstract][Full Text] [Related]
27. Genetic evaluation of inherited motor/sensory neuropathy.
Chance PF
Suppl Clin Neurophysiol; 2004; 57():228-42. PubMed ID: 16106622
[TBL] [Abstract][Full Text] [Related]
28. Molecular basis of hereditary neuropathies.
Chance PF
Phys Med Rehabil Clin N Am; 2001 May; 12(2):277-91. PubMed ID: 11345007
[TBL] [Abstract][Full Text] [Related]
29. The PMP22 gene and its related diseases.
Li J; Parker B; Martyn C; Natarajan C; Guo J
Mol Neurobiol; 2013 Apr; 47(2):673-98. PubMed ID: 23224996
[TBL] [Abstract][Full Text] [Related]
30. Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A.
Sancho S; Young P; Suter U
Brain; 2001 Nov; 124(Pt 11):2177-87. PubMed ID: 11673320
[TBL] [Abstract][Full Text] [Related]
31. The peripheral myelin protein 22 and epithelial membrane protein family.
Jetten AM; Suter U
Prog Nucleic Acid Res Mol Biol; 2000; 64():97-129. PubMed ID: 10697408
[TBL] [Abstract][Full Text] [Related]
32. Colocalization Analysis of Peripheral Myelin Protein-22 and Lamin-B1 in the Schwann Cell Nuclei of Wt and TrJ Mice.
Di Tomaso MV; Vázquez Alberdi L; Olsson D; Cancela S; Fernández A; Rosillo JC; Reyes Ábalos AL; Álvarez Zabaleta M; Calero M; Kun A
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327648
[TBL] [Abstract][Full Text] [Related]
33. Genetic basis of inherited peripheral neuropathies.
Suter U; Patel PI
Hum Mutat; 1994; 3(2):95-102. PubMed ID: 7515304
[TBL] [Abstract][Full Text] [Related]
34. Autosomal dominant Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies: detection of the recombination in Slovene patients and exclusion of the potentially recessive Thr118Met PMP22 point mutation.
Leonardis L; Zidar J; Ekici A; Peterlin B; Rautenstrauss B
Int J Mol Med; 1998 Feb; 1(2):495-501. PubMed ID: 9852256
[TBL] [Abstract][Full Text] [Related]
35. Dejerine-Sottas disease in childhood-Genetic and sonographic heterogeneity.
Hobbelink SMR; Brockley CR; Kennedy RA; Carroll K; de Valle K; Rao P; Davis MR; Laing NG; Voermans NC; Ryan MM; Yiu EM
Brain Behav; 2018 Apr; 8(4):e00919. PubMed ID: 29670817
[TBL] [Abstract][Full Text] [Related]
36. [Mutation of the myelin Po gene in hereditary motor and sensory neuropathy].
Hayasaka K
Rinsho Shinkeigaku; 1995 Dec; 35(12):1444-6. PubMed ID: 8752425
[TBL] [Abstract][Full Text] [Related]
37. Compound heterozygous deletions of PMP22 causing severe Charcot-Marie-Tooth disease of the Dejerine-Sottas disease phenotype.
Al-Thihli K; Rudkin T; Carson N; Poulin C; Melançon S; Der Kaloustian VM
Am J Med Genet A; 2008 Sep; 146A(18):2412-6. PubMed ID: 18698610
[TBL] [Abstract][Full Text] [Related]
38. Regulation of myelin-specific gene expression. Relevance to CMT1.
Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
[TBL] [Abstract][Full Text] [Related]
39. Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of Spanish ancestry with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies.
Bort S; Nelis E; Timmerman V; Sevilla T; Cruz-Martínez A; Martínez F; Millán JM; Arpa J; Vílchez JJ; Prieto F; Van Broeckhoven C; Palau F
Hum Genet; 1997 Jun; 99(6):746-54. PubMed ID: 9187667
[TBL] [Abstract][Full Text] [Related]
40. Peripheral myelin protein 22: facts and hypotheses.
Suter U; Snipes GJ
J Neurosci Res; 1995 Feb; 40(2):145-51. PubMed ID: 7745607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
